Australian Teletrial Program (ATP) Project

The Australian Teletrial Program is supported by funding from the Australian Government under the Medical Research Future Fund. The Program has been funded $75.2 million over five years to bring clinical trials closer to home for patients in Queensland, Victoria, Tasmania, South Australia, Western Australia and the Northern Territory.

ACTA’s role

ACTA have partnered with the Australian Teletrial Program to help in the development of Teletrials as a way to bring safe, cost effective and quality trials closer to home for many Australians. The project will deliver capacity building and education for Clinical Trial Networks and Coordinating Centres, to help plan and run Teletrials across regional, rural and remote sites in Australia and across all therapeutic areas.

ACTA Contact

Dr Jo Youd
Clinical Trials Specialist
Mobile: +61 402 987 990

ATP Website:

ATP Email: 

ATP Regional Clinical Trial Coordinating Centres (RCCC’s)

Contact details for the RCCC in each state and jurisdiction:


Further details to follow.

ACTA Webinar: The Australian Teletrial Experience: Tales from the Frontline

This webinar, held on November 21, featured speakers who shared their experiences and insights on the challenges, hurdles, and successes of running Teletrials within clinical trial networks.

Speakers included:

  • Gabrielle Byars, Chief Executive Officer – Melanoma and Skin Cancer Trials (MASC)
  • Naomi Sprigg, Clinical Operations Manager – Australasian Leukaemia & Lymphoma Group (ALLG)
  • Jonathon Lennon, Clinical Trial Operations Coordinator – NHMRC CTC
  • Kelly Foran, RRR consumer Rep

Watch the webinar – watch the webinar